Xvivo Perfusion AB (publ) (0RKL.L)

274.02 -1.91 (-0.69%) At close: 05:12PM BST

Xvivo Perfusion AB (publ)

MAessans gata 10
Gothenburg 412 51
Sweden
46 3 17 88 21 50
https://www.xvivoperfusion.com

Sector(s): 
Industry: 
Full-time employees: 142

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Christoffer Rosenblad	Chief Exec. Officer	N/A	N/A	1975
Mr. Kristoffer Nordstrom	CFO & Investor Relations	N/A	N/A	1985
Ms. Lena Hagman B.Sc.	Chief Operating Officer	N/A	N/A	1965
Dr. Magnus Nilsson Ph.D.	Sr. Advisor	N/A	N/A	1956
Mr. Andreas Wallinder M.D., Ph.D.	Chief Medical Officer	N/A	N/A	1977
Mr. Johan Holmstrom	Chief Commercial Officer	N/A	N/A	1970

Amounts are as of , and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in SEK.

Description

Xvivo Perfusion AB (publ), a medical technology company, develops solutions for organ, tissue, and cell preservation and perfusion in connection with transplantation in Sweden, the United States, North America and South America, Europe, the Middle East, Africa, and the Asia Pacific. The company offers XVIVO System (XPS), an integrated off-the-shelf cardiac bypass system that includes various components needed to safely run normothermic ex vivo lung perfusion (EVLP); XPS Disposable Lung Kit that contains disposables and pre-packed products to suit requirement for sterility; and STEEN Solution, a buffered extracellular solution optimally designed to perfuse the isolated donor lung during EVLP. It also provides Perfadex Plus, an extracellular, low potassium, dextran-based electrolyte preservation solution; XVIVO Silicone Tubing Set for rapid flushing of donor lungs during procurement; and XVIVO LS and XVIVO Disposable Lung Set, a device for EVLP. In addition, the company offers XVIVO Organ Chamber, a single-use sterile disposable container intended to be used as a temporary receptacle for isolated lungs in preparation for eventual transplantation into a recipient; and XVIVO Lung Cannula Set, a single-use, sterile disposable product. The company was incorporated in 1998 and is headquartered in Gothenburg, Sweden.

Corporate governance

Xvivo Perfusion AB (publ)’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.